Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Northwestern University
Northwestern University
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Shanghai Zhangjiang Biotechnology Limited Company
Northwestern University
Mayo Clinic
Fred Hutchinson Cancer Center
University of Ulm
German CLL Study Group
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
University of Arizona
Ohio State University Comprehensive Cancer Center
University of Chicago
German CLL Study Group
German CLL Study Group
Sanofi
Merck Sharp & Dohme LLC
Stanford University
Mayo Clinic
National Cancer Institute (NCI)
Sanofi
Northside Hospital, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Charite University, Berlin, Germany
Chronic Lymphocytic Leukemia Research Consortium